Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
bioAffinity Technologies, Inc. ( (BIAF) ) has issued an update.
On January 10, 2025, bioAffinity Technologies, Inc. announced that its Compensation Committee approved an amendment to increase the annual base salary of CEO Maria Zannes to $300,000, effective retroactively from November 1, 2024. This adjustment to the CEO’s compensation package reflects ongoing strategic decisions within the company that could have implications for its financial management and stakeholder relations.
More about bioAffinity Technologies, Inc.
YTD Price Performance: -19.79%
Average Trading Volume: 207,866
Technical Sentiment Consensus Rating: Buy
Learn more about BIAF stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue